A phase II study of Epothilone B analog BMS-247550 (NSC 710428) in patients with relapsed aggressive non-Hodgkin’s lymphomas No significant financial relationships to disclose. This is an ASCO Meeting ...
The PRONTO amyloidosis study: A randomized, double-blind, placebo-controlled, global, phase 2b study of NEOD001 in previously treated subjects with light chain amyloidosis and persistent cardiac ...
We recently described the TEMPI syndrome (Aug. 4, 2011), 1 which is characterized by the pentad of telangiectasias, elevated erythropoietin level and erythrocytosis, monoclonal gammopathy, perinephric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results